$ALB

ALBEMARLE CORP

3
4
1

No SEC Form 4 filings for $ALB in the last 30 days.

Med

Pinkerton Wealth LLC Takes Position in Albemarle Corporation $ALB

Pinkerton Wealth LLC has acquired a new stake in Albemarle Corporation (NYSE:ALB), purchasing 19,689 shares valued at approximately $2.785 million in the fourth quarter. Other institutional investors also modified their holdings, with significant increases from Northwestern Mutual Wealth Management Co. and Worldquant Millennium Advisors LLC. The article also notes recent insider selling by CEO J Kent Masters and provides financial details, dividend information, and updated analyst ratings for the specialty chemicals company.

Albemarle Corp. stock (US0126531013): lithium producer adjusts strategy amid weak prices and cost cu

Albemarle Corp. is adjusting its strategy by implementing cost cuts, project delays, and focusing on high-return assets in response to falling lithium prices. Despite recent profitability challenges driven by commodity price volatility, the company maintains a long-term positive outlook on lithium demand due to electrification and energy storage trends. This strategy aims to protect its balance sheet while solidifying its position as a leading lithium supplier, particularly for electric vehicle batteries.

Albemarle Corp. stock (US0126531013): CEO share sale follows solid first-quarter results

Albemarle Corp. reported strong first-quarter 2026 results, surpassing analyst expectations with approximately $1.4 billion in revenue. Following this, CEO J. Kent Masters sold over 16,000 company shares in open-market transactions, totaling about $3.0 million, though he retained a substantial holding. The article highlights Albemarle's core business in lithium and specialty chemicals, its competitive position in the global lithium market, and its relevance to US investors interested in the energy transition.